Journal Title
DRUG DISCOVERY TODAY

DRUG DISCOV TODAY

ISSN / eISSN
1359-6446 / 1878-5832
Aims and Scope
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.

Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
Coverage includes:
• Novel therapeutic strategies
• High-throughput screening
• Therapeutic targets
• Combinatorial chemistry, parallel synthesis and library design
• Drug delivery
• ADME/Tox
• Advances in key compound classes and therapeutic areas
• Genomics and proteomics
• Automation and technology
• Virtual chemistry
• Informatics
• Business strategy
• Clinical trials
and other aspects of drug discovery.
Subject Area

PHARMACOLOGY & PHARMACY

CiteScore
14.70 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #15/301
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery Q1 #11/156
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
PHARMACOLOGY & PHARMACY - SCIE Q1
H-index
157
Country/Area of Publication
ENGLAND
Publisher
Elsevier Ltd
Publication Frequency
Semimonthly
Year Publication Started
1996
Annual Article Volume
297
Open Access
NO
Contact
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
I am so happy that we had two more articles published in this journal in Feb. 2021.
The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
T Xie, XL Song, C Wang, YZ Yu, JQ Wang, ZS Chen, SC Zhao
Drug Discovery Today 2021
Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
XY Liu, JQ Wang, CR Ashby Jr, L Zeng, YF Fan, ZS Chen
Drug Discovery Today
2021-02-14
The classification of the Chinese Academy of Sciences is becoming more and more absurd. Surprisingly, DDT has been placed in the second tier, and not even in the top. From now on, let's not say anything. All the journals managed by China should be considered top-tier in the first tier...
2021-12-26

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started